News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

2019 Clinical & Scientific Conference Highlight: What’s New in Neuromuscular Diseases?

By Jeanene Swanson | July 10, 2019
Blog Post

2019 Clinical & Scientific Conference Highlight: Neuromuscular Disease Impacts Cognition and Behavior, Too

By Ori Rokach | July 9, 2019
Blog Post

2019 Clinical & Scientific Conference Highlight: Physical, Occupational, and Speech Therapy Considerations in NMD

By Ori Rokach | July 8, 2019
Blog Post

The Christopher Project Report to the Myotonic Dystrophy Community is Now Available

By Jeanene Swanson | July 5, 2019
Blog Post

MDA Awards Venture Philanthropy Funding to Locana to Develop Novel Treatment for DM

By Jeanene Swanson | June 12, 2019
Blog Post

FDA Approves PTC Therapeutics’ Emflaza for the Treatment of DMD in Patients Between 2 and 5 Years Old

By Jeanene Swanson | June 10, 2019
Blog Post

Congress is Considering a Law to Strengthen Newborn Screening: Help MDA Promote its Passage

By Brittany Hernandez | June 4, 2019
Blog Post

Clinical Trial Alert: Biogen Seeks Participants for a Phase 3 SOD1-ALS Study

By MDA Staff | May 30, 2019
Blog Post

Clinical Trial Alert: Alexion Pharmaceuticals Seeks Participants for a Phase 3 Pediatric Myasthenia Gravis Study

By MDA Staff | May 30, 2019
Blog Post

JAMA Neurology Publishes Article on Newborn Screening and Neuromuscular Disorders

By MDA Staff | May 24, 2019